Evidence map›Paper›PMID 39371172›Full record

ArticlemedRxiv : the preprint server for health sciences2024

Gut microbiome shifts in adolescents after sleeve gastrectomy with increased oral-associated taxa and pro-inflammatory potential.

Cynthia O Akagbosu, Kathryn E McCauley, Sivaranjani Namasivayam, Hector N Romero-Soto, Wade O'Brien, Mickayla Bacorn, Eric Bohrnsen, Benjamin Schwarz, Shreni Mistry, Andrew S Burns and 13 more

Abstract readPreprint
In one paragraph

Article in medRxiv : the preprint server for health sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

23 authors.

Cynthia O AkagbosuDepartment of Gastroenterology. Weill Cornell Medicine. New York, New York, United States.
Kathryn E McCauleyBioinformatics and Computational Biosciences Branch National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States.
Sivaranjani NamasivayamClinical Microbiome Unit. National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States.
Hector N Romero-SotoClinical Microbiome Unit. National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States.
Wade O'BrienDartmouth Geisel School of Medicine, Dartmouth College, Hanover, New Hampshire, United States.
Mickayla BacornClinical Microbiome Unit. National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States.
Eric BohrnsenResearch Technologies Branch, National Institute of Allergy and Infectious Diseases, Division of Intramural Research, Rocky Mountain Laboratories, National Institutes of Health, Hamilton, Montana, United States.
Benjamin SchwarzResearch Technologies Branch, National Institute of Allergy and Infectious Diseases, Division of Intramural Research, Rocky Mountain Laboratories, National Institutes of Health, Hamilton, Montana, United States.
Shreni MistryNIAID Microbiome Program, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States.
Andrew S BurnsNIAID Microbiome Program, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States.
P Juliana Perez-ChaparroNIAID Microbiome Program, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States.
Qing ChenClinical Microbiome Unit. National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States.
Phoebe LaPointClinical Microbiome Unit. National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States.
Anal PatelClinical Microbiome Unit. National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States.
Lauren E KrausfeldtBioinformatics and Computational Biosciences Branch National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States.
Poorani SubramanianBioinformatics and Computational Biosciences Branch National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States.
Brian A SellersNIH Center for Human Immunology, Autoimmunity, and Inflammation (CHI), Bethesda, Maryland, United States.
Foo CheungNIH Center for Human Immunology, Autoimmunity, and Inflammation (CHI), Bethesda, Maryland, United States.
Richard AppsNIH Center for Human Immunology, Autoimmunity, and Inflammation (CHI), Bethesda, Maryland, United States.
Iyadh DouagiNIH Center for Human Immunology, Autoimmunity, and Inflammation (CHI), Bethesda, Maryland, United States.
Shira LevyClinical Microbiome Unit. National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States.
Evan P NadlerEvan P Nadler. ProCare Consultants, Washington DC, Washington DC, United States.
Suchitra K HouriganClinical Microbiome Unit. National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States.

Funding

Research in Academic Pediatrics Investigator Development (RAPID)R25DK096944 · NIDDK · ACADEMIC PEDIATRIC ASSOCIATION · PI GLENN FLORES · 2012 to 2026
$2.0M
NIDDK NIH HHS R25 DK096944
6 · The paper itself

Abstract

Background: Bariatric surgery is highly effective in achieving weight loss in children and adolescents with severe obesity, however the underlying mechanisms are incompletely understood, and gut microbiome changes are unknown. Objectives: 1) To comprehensively examine gut microbiome and metabolome changes after laparoscopic vertical sleeve gastrectomy (VSG) in adolescents and 2) to assess whether the microbiome/metabolome changes observed with VSG influence phenotype using germ-free murine models. Design: 1) A longitudinal observational study in adolescents undergoing VSG with serial stool samples undergoing shotgun metagenomic microbiome sequencing and metabolomics (polar metabolites, bile acids and short chain fatty acids) and 2) a human-to-mouse fecal transplant study. Results: We show adolescents exhibit significant gut microbiome and metabolome shifts several months after VSG, with increased alpha diversity and notably with enrichment of oral-associated taxa. To assess causality of the microbiome/metabolome changes in phenotype, pre-VSG and post-VSG stool was transplanted into germ-free mice. Post-VSG stool was not associated with any beneficial outcomes such as adiposity reduction compared pre-VSG stool. However, post-VSG stool exhibited an inflammatory phenotype with increased intestinal Th17 and decreased regulatory T cells. Concomitantly, we found elevated fecal calprotectin and an enrichment of proinflammatory pathways in a subset of adolescents post-VSG. Conclusion: We show that in some adolescents, microbiome changes post-VSG may have inflammatory potential, which may be of importance considering the increased incidence of inflammatory bowel disease post-VSG.

Indexed as

adolescentsbariatric surgerychildhood obesitychildrendyslipidemiainflammationmetabolomemicrobiotaobesitypediatricsleeve gastrectomytype 2 diabetes mellitus

Identifiers

PMID39371172
PMCPMC11451705

What Socratic holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.